| Application no. and date | 13795435.0 (espacenet) (Federated) (European Patent Register), 20131011 | | Patent/reg. no. and date | DK/EP 2906253, 20180801 | | Publication date | 20150819 | | Priority no. and date | US 201261712928 P, 20121012, US 201261712924 P, 20121012, US 201361784460 P, 20130314, US 201361784477 P, 20130314, US 201361784525 P, 20130314 | | EP pub. no. and date |
EP 2906253 20150819 | | Effective date | | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB,
ADC Therapeutics SA, route de la Corniche 3B
1066 Epalinges, CH | | Applicant ref. no. | P81803252DK00E | | Inventor | HOWARD, Philip Wilson, Spirogen Limited
The QMB Innovation Centre
42 New Road
London
Greater London E1 2AX, GB,
VAN BERKEL, Patricius Hendrikus Cornelis, ADC Therapeutics Sàrl
Rue Saint-Pierre 2
c/o Michael Forer
1003 Lausanne, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) | | Title | PYRROLOBENZODIAZEPIN-ANTI-PSMA-ANTISTOFKONJUGATER | | Int. application no. | EP2013071341 | | Int. publication no. | WO2014057113 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
